The effects of AST-120 on chronic kidney disease progression in the United States of America: a post hoc subgroup analysis of randomized controlled trials

Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis

(2016) Maleeka Ladhani et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

GFR Decline and Subsequent Risk of Established Kidney Outcomes: A Meta-analysis of 37 Randomized Controlled Trials

(2014) Hiddo J. Lambers Heerspink et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

GFR Decline as an Alternative End Point to Kidney Failure in Clinical Trials: A Meta-analysis of Treatment Effects From 37 Randomized Trials

(2014) Lesley A. Inker et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality

(2014) Josef Coresh et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Randomized Placebo-Controlled EPPIC Trials of AST-120 in CKD

(2014) G. Schulman et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Estimated GFR Decline as a Surrogate End Point for Kidney Failure: A Post Hoc Analysis From the Reduction of End Points in Non–Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) Study and Irbesartan Diabetic Nephropathy Trial (IDNT)

(2013) Hiddo J. Lambers Heerspink et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Standards of Medical Care in Diabetes--2014

(2013)   DIABETES CARE

Comments on ‘KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease’

(2013) Konrad M. Andrassy   KIDNEY INTERNATIONAL

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

(2012)   AMERICAN JOURNAL OF KIDNEY DISEASES

Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting

(2012) Elise M. Pelletier et al.   Applied Health Economics and Health Policy

Cost-effectiveness of administering oral adsorbent AST-120 to patients with diabetes and advance-stage chronic kidney disease

(2010) Yasuaki Hayashino et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Level of renal function in patients starting dialysis: an ERA-EDTA Registry study

(2010) V. S. Stel et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients

(2009) F. C. Barreto et al.   Clinical Journal of the American Society of Nephrology

Serum indoxyl sulfate levels in patients with diabetic nephropathy: Relation to renal function

(2008) Keita Atoh et al.   DIABETES RESEARCH AND CLINICAL PRACTICE